Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug
Therapeutic nanoparticles (TNPs) aim to deliver drugs more safely and effectively to cancers, yet clinical results have been unpredictable owing to limited in vivo understanding. Here we use single-cell imaging of intratumoral TNP pharmacokinetics and pharmacodynamics to better comprehend their hete...
Main Authors: | Miller, Miles Aaron, Zheng, Yao-Rong, Gadde, Suresh, Pfirschke, Christina, Zope, Harshal, Engblom, Camilla, Kohler, Rainer H., Iwamoto, Yoshiko, Yang, Katherine S., Askevold, Bjorn, Kolishetti, Nagesh, Pittet, Mikael, Lippard, Stephen J., Farokhzad, Omid C., Weissleder, Ralph |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Chemistry |
Format: | Article |
Language: | en_US |
Published: |
Nature Publishing Group
2015
|
Online Access: | http://hdl.handle.net/1721.1/100507 https://orcid.org/0000-0002-2693-4982 |
Similar Items
-
Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo
by: Dhar, Shanta, et al.
Published: (2011) -
PF4 Promotes Platelet Production and Lung Cancer Growth
by: Pucci, Ferdinando, et al.
Published: (2017) -
α[subscript v]β[subscript 3] Integrin-Targeted PLGA-PEG Nanoparticles for Enhanced Anti-tumor Efficacy of a Pt(IV) Prodrug
by: Graf, Nora, et al.
Published: (2013) -
Origins of tumor-associated macrophages and neutrophils
by: Cortez-Retamozo, Virna, et al.
Published: (2014) -
Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy
by: Kolishetti, Nagesh, et al.
Published: (2013)